Early treatment of blinding eye disease in infants can prevent severe vision loss

Researchers at The Children's Hospital of Philadelphia, and 25 other centers, have concluded that earlier treatment of premature infants affected with severe retinopathy of prematurity can result in better outcomes and a reduced risk of blindness or vision impairment for these infants. This also helped to define high-risk groups among premature infants with the disease most likely to benefit from the treatment.

These findings may also lead to better screening protocols of premature infants' eyes while they are under observation in hospital's newborn intensive care units. The results of the multicenter Early Treatment for Retinopathy of Prematurity (ETROP) study are published in the December issue of the Archives of Ophthalmology.

A leading cause of vision loss in infants, retinopathy of prematurity (ROP) is a potentially blinding disease that affects premature, low birth weight infants. ROP is the growth of abnormal blood vessels in the back of the eye. These vessels can leak fluid and blood and lead to scar tissue inside the eye, increasing the risk of retinal detachment and severe vision loss.

Each year ROP affects an estimated 14,000 to 16,000 premature, low birth weight infants in the United States and thousands more worldwide. Of these cases, approximately 1,500 infants will develop severe ROP that requires treatment. Despite available treatment, about 400 to 600 infants with ROP still become legally blind each year.

"This study represents another important step in our ongoing efforts to decrease preventable blindness in premature babies, said Graham Quinn, M.D., MSCE, principal investigator at the Philadelphia Center (The Children's Hospital of Philadelphia, Hospital of the University of Pennsylvania and Pennsylvania Hospital). "We have identified a group of children whose eyes would not have been treated before using the conventional threshold definition, but many of these eyes clearly benefited from earlier treatme

Contact: Joey Marie McCool
Children's Hospital of Philadelphia

Page: 1 2 3

Related medicine news :

1. Early onset of puberty the EU gets serious
2. Early HIV screening prolongs life and is affordable, Stanford study shows
3. Early supported discharge services can reduce long term dependency for stroke patients
4. Early surgical treatment not always necessary for patients with brain haemorrhage
5. Early seizures after epilepsy surgery predict more seizures
6. Early learning leaves lasting changes in brain, Stanford owl study shows
7. Early detection reduces threat of foot injury in college basketball players
8. Early results shed light on lung cancer screening advance
9. Early disclosure: Post-operative radiotherapy improves progression-free survival in prostate cancer
10. Early reports of thrombosis after insertion of drug-eluting stents
11. Early behavior problems linked with wheezing later in childhood

Post Your Comments:

(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... -- Consumer reviews on the independent review site Consumer Affairs ... for hearing aids, ranking it higher than Miracle Ear ™, ... ... Hearing Aids ... store that provides high performance, state-of-the-art, German-engineered hearing aids directly to ...
Breaking Medicine Technology:
Cached News: